• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Colorectal Cancer Risk Factors Important to Consider for Rescreening Interval

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 3, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Dec. 3, 2024 -- Colorectal cancer (CRC) risk factors are important to consider when making decisions for colonoscopy rescreening following negative colonoscopy screening (NCS) results (no presence of CRC or polyps), according to a study published online Nov. 27 in JAMA Oncology.

Markus Dines Knudsen, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined long-term CRC incidence and mortality after NCS results and by risk score using major demographic and lifestyle risk factors. The analysis included data from three prospective U.S. population-based cohorts, including the Nurses’ Health Study, Nurses’ Health Study II, and Health Professionals Follow-up Study (1988 and 1991 to 2020; 195,453 participants), as well as data from the National Health and Nutrition Examination Survey (from 2017 through 2018).

The researchers found that negative colonoscopy screening results were consistently associated with lower CRC incidence (hazard ratio, 0.51) and mortality (hazard ratio, 0.56) for 20 years. For those with NCS results and intermediate risk (scores, 6 to 7) or low risk (scores, 0 to 5), the 10-year cumulative incidence of CRC (0.78 percent) of the high-risk individuals (scores, 8 to 12) was not reached until 16 and 25 years after initial screening, respectively.

“These findings provide evidence for shared decision-making between patients and physicians to consider extending the rescreening intervals after an NCS result beyond the currently recommended 10 years, particularly for individuals with a low-risk profile," the authors write.

Two authors disclosed ties to the pharmaceutical and biotechnology industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted December 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.